Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Effect of renal function loss on NT-proBNP level variations.

Bernstein LH, Zions MY, Haq SA, Zarich S, Rucinski J, Seamonds B, Berger S, Lesley DY, Fleischman W, Heitner JF.

Clin Biochem. 2009 Jul;42(10-11):1091-8. doi: 10.1016/j.clinbiochem.2009.02.027. Epub 2009 Mar 17.

PMID:
19298805
2.

Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Clin Chem. 2007 Nov;53(11):1928-35. Epub 2007 Sep 14.

3.

N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).

Astor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson G, Lewis J, Lash JP, Van Lente F, Gassman J, Wang X, Bakris G, Appel LJ, Contreras G.

Circulation. 2008 Apr 1;117(13):1685-92. doi: 10.1161/CIRCULATIONAHA.107.724187. Epub 2008 Mar 24.

4.

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure.

Gardner RS, Chong KS, O'Meara E, Jardine A, Ford I, McDonagh TA.

Eur Heart J. 2007 Dec;28(24):3027-33. Epub 2007 Oct 29.

PMID:
17967819
5.

[Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].

Ishii J.

Rinsho Byori. 2008 Apr;56(4):316-21. Review. Japanese.

PMID:
18516966
6.

N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction.

Szadkowska I, Goch JH, Kawiński J, Chizyński K.

Clin Cardiol. 2008 Sep;31(9):443-7. doi: 10.1002/clc.20278.

7.

Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea.

Reny JL, Millot O, Vanderecamer T, Vergnes C, Barazer I, Sedighian S, Berdagué P.

Eur J Intern Med. 2009 Jan;20(1):14-9. doi: 10.1016/j.ejim.2008.03.006. Epub 2008 Apr 29.

PMID:
19237086
8.

Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.

Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA.

J Vet Cardiol. 2009 May;11 Suppl 1:S81-6. doi: 10.1016/j.jvc.2009.02.001. Epub 2009 Apr 25.

PMID:
19394913
9.

Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.

Palmer SC, Yandle TG, Frampton CM, Troughton RW, Nicholls MG, Richards AM.

Eur Heart J. 2009 Jun;30(12):1486-94. doi: 10.1093/eurheartj/ehp132. Epub 2009 Apr 23.

PMID:
19389787
10.

Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.

Linzbach S, Samigullin A, Yilmaz S, Tsioga M, Zeiher AM, Spyridopoulos I.

Am J Cardiol. 2009 Apr 15;103(8):1128-33. doi: 10.1016/j.amjcard.2009.01.009. Epub 2009 Mar 4.

PMID:
19361601
11.
12.

Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM.

J Clin Oncol. 2009 Sep 10;27(26):4293-9. doi: 10.1200/JCO.2008.18.7047. Epub 2009 Aug 10.

PMID:
19667278
13.

The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.

van der Burg-de Graauw N, Cobbaert CM, Middelhoff CJ, Bantje TA, van Guldener C.

Eur J Intern Med. 2009 May;20(3):301-6. doi: 10.1016/j.ejim.2008.09.022. Epub 2008 Nov 17.

PMID:
19393498
14.

The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.

Provan SA, Angel K, Odegård S, Mowinckel P, Atar D, Kvien TK.

Arthritis Res Ther. 2008;10(3):R70. doi: 10.1186/ar2442. Epub 2008 Jun 23.

15.

Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).

Das SR, Abdullah SM, Leonard D, Drazner MH, Khera A, McGuire DK, de Lemos JA.

Am J Cardiol. 2008 Nov 15;102(10):1394-8. doi: 10.1016/j.amjcard.2008.07.018. Epub 2008 Sep 11.

PMID:
18993162
16.

The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.

Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M.

Rom J Intern Med. 2009;47(1):35-40.

PMID:
19886067
17.

Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone.

Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS.

Clin Chem. 2009 Oct;55(10):1869-75. doi: 10.1373/clinchem.2009.123778. Epub 2009 Aug 13.

18.

Introduction of an NT-proBNP assay to an acute admission unit--a 2-year audit.

Murtagh G, Canniffe C, Mahgoub M, Blake L, McCarroll N, Crowley V, Bennett K, Silke B.

Eur J Intern Med. 2009 Jan;20(1):58-62. doi: 10.1016/j.ejim.2008.04.021. Epub 2008 Jul 16.

PMID:
19237094
19.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
20.

The influence of renal function on NT-proBNP levels in various disease groups.

Herrmann Z, Uhl W, Steinberg HW, Dworschack R.

Clin Lab. 2003;49(11-12):649-56. No abstract available.

PMID:
14651336

Supplemental Content

Support Center